Anna Rivkin
CIK: 0002035647
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Foghorn Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 30, 2026FHTX
Foghorn Therapeutics Inc.
Award(A)DirectStock option (right to buy)
165K shares at avg. $5.71- - Jan 22, 2025FHTX
Foghorn Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
50K shares at avg. $4.37- - Sep 3, 2024FHTX
Foghorn Therapeutics Inc.
Award(A)DirectStock Options (Right to buy)
190K shares at avg. $7.85-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 30, 2026 | FHTX Foghorn Therapeutics Inc. | Award(A) Stock option (right to buy) | 165,000 | $5.71 | - | Direct |
| Jan 22, 2025 | FHTX Foghorn Therapeutics Inc. | Award(A) Stock Option (right to buy) | 50,000 | $4.37 | - | Direct |
| Sep 3, 2024 | FHTX Foghorn Therapeutics Inc. | Award(A) Stock Options (Right to buy) | 190,000 | $7.85 | - | Direct |
1-3 of 3 transactions
About Rivkin Anna
Rivkin Anna (SEC CIK 0002035647) files insider reports with the SEC as Chief Business Officer of Foghorn Therapeutics Inc. (FHTX).
Signal8 holds 4 ownership filings by Rivkin Anna (1 Form 3, 3 Form 4), filed between Sep 4, 2024 and Feb 2, 2026. Those filings report 3 transactions, from Sep 3, 2024 to Jan 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rivkin Anna's filings is in WATERTOWN, MA.
Recent filings by Rivkin Anna
Other insiders filing for Foghorn Therapeutics Inc. (FHTX)
- BVF PARTNERS L P/IL, 10% Owner
- Lynch Thomas J. Jr., Director
- Duty Stuart, Director
- Biller Scott, Director
- Gallagher Neil, Director
- Mendelsohn Michael, Director